Menora Mivtachim Holdings’s bluebird bio BLUE Stock Holding History

Menora Mivtachim Holdings’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,939	Closed	-$18M	–	63
2019 Q2	$18M	Hold	10,939	–	–	0.49%	51
2019 Q1	$22.3M	Hold	10,939	–	–	0.6%	53
2018 Q4	$14.1M	Hold	10,939	–	–	0.41%	66
2018 Q3	$20.7M	Hold	10,939	–	–	0.56%	70
2018 Q2	$22.2M	Hold	10,939	–	–	0.63%	58
2018 Q1	$24.2M	Buy	10,939 +3,837	+54%	+$9.76M	0.77%	47
2017 Q4	$16.4M	Buy	+7,102	New	+$14.4M	0.63%	61

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Menora Mivtachim Holdings's BLUE Position: Q3 2019 in Review

Menora Mivtachim Holdings sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 10,939 shares — an estimated $18M sold.

Menora Mivtachim Holdings first reported a position in BLUE in Q4 2017 and held it in 7 quarters. The position peaked at $24.2M in Q1 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

Menora Mivtachim Holdings reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
Menora Mivtachim Holdings sold 10,939 bluebird bio shares in Q3 2019, an estimated $18M.
Menora Mivtachim Holdings first reported a position in bluebird bio in Q4 2017 and held it in 7 quarters.
Menora Mivtachim Holdings's bluebird bio position peaked at $24.2M in Q1 2018.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Menora Mivtachim Holdings's 13F filing for Q3 2019, filed 31 Oct 2019.